|
A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits Clinical research trials and A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits. A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits clinical trial. Human subjects often get the best healthcare available for their A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits  A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
For Condition: Schizophrenia
Status: Recruiting
Sponsor(s): Johnson & Johnson Pharmaceutical Research and Development, L.L.C. ,
Synopsis: This is an exploratory study which will evaluate Galantamine in cognitive deficits (learning) in patients with schizophrenia. The trial will last for 8 weeks. Efficacy and safety will be studied. The patients must be on a stable dose of an antipsychotic and smoke cigarettes.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/55 Years
Genders: Both
Protocol Entry Criteria: - Patient must be on a stable atypical antipsychotic for at least 30 days - Women of child bearing potential must use approved method of birth control - Patients must smoke at least 5 cigarettes per day - Patient cannot have major medical problems
Total Enrollment: 100
Location and Contact Information:
Health Sciences Center *Recruiting*
Winnipeg, Manitoba, R3E 3N4
Canada
Recruiting Brendon Foot 204-787-3246
Psychopharmcology Research Unit *Recruiting*
Edmonton, Alberta, T6G 2B7
Canada
Recruiting Rawle Carter 780-407-1589
Foothills Medical Center *Recruiting*
Calgary, Alberta, T2N T9
Canada
Recruiting Geri Anderson 403-944-1050
Providence Continuing Care Center *Recruiting*
Kingston, Ontario, K7L 4X3
Canada
Recruiting Ann Shea 613-548-5567
Royale Ottawa Hospital *Recruiting*
Ottawa, Ontario, K17 7K4
Canada
Recruiting Sandhya Patel 613-722-6521
Additional Information:
Study ID Numbers: GAL-SCH-201;
Study Start Date: May 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00077727
Other Schizophrenia Studies:
1. Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
2. A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
3. Antipsychotic Response in Schizophrenia
4. Schizophrenia Study
5. Rehabilitative Training for Older People with Schizophrenia
Related Studies:
Other Schizophrenia Clinical Trials
Other Ontario Clinical Trials
Other Ottawa Clinical Trials
A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
|
|
|
|
|
|
|
|
